Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: Results of a German multicenter observational study

Jalid Sehouli, O. Camara, M. Schmidt, S. Mahner, G. Seipelt, B. Otremba, B. Schmalfeldt, H. Tesch, C. Lorenz-Schlüter, G. Oskay-Özcelik

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: Results of a German multicenter observational study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science